Skip to main content
Clinical Trials/NCT02877563
NCT02877563
Unknown
N/A

Contrast Ultrasound Assessment of Perfusion Changes After Peripheral Artery Revascularization

Oregon Health and Science University1 site in 1 country30 target enrollmentJune 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Peripheral Artery Disease
Sponsor
Oregon Health and Science University
Enrollment
30
Locations
1
Primary Endpoint
Skeletal muscle perfusion during exercise stress
Last Updated
7 years ago

Overview

Brief Summary

This study represents an important step to validate the use of contrast-enhanced ultrasound (CEU) as a clinical research tool that can be used as a biologic readout of new therapies for Peripheral Artery Disease (PAD), and as a clinically-reasonable method for assessing impact of revascularization. The primary aim is to establish that CEU limb perfusion imaging can be used to accurately assess therapeutic improvements in tissue perfusion that are linked to symptom improvement.

Detailed Description

The study will be performed in patients with known history of PAD that are scheduled to undergo either surgical or percutaneous revascularization. Limb rest-stress CEU perfusion imaging will be performed before and 3-4 weeks after revascularization. Quantitative measurements of pre-revascularization perfusion, post-revascularization perfusion, and change in perfusion will be compared to symptom status (Rutherford classification and PAD \[Criqui\] questionnaire) at each study point, and to data on time to onset of claudication on an upright treadmill exercise study (Gardiner protocol). Results of angiography will be scored and allow determination of the relationship between angiographic severity of disease and exercise perfusion.

Registry
clinicaltrials.gov
Start Date
June 1, 2018
End Date
December 31, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jonathan R. Lindner, MD

Professor

Oregon Health and Science University

Eligibility Criteria

Inclusion Criteria

  • History of symptomatic PAD
  • Rutherford score \<6
  • Age ≥18 y.o.
  • Scheduled to undergo surgical or percutaneous revascularization

Exclusion Criteria

  • Major medical illness affecting the limb other than PAD (muscle disease, neuromuscular disease, blood diseases).
  • Pregnant or lactating females (- HCG in women of child bearing age)
  • Hypersensitivity to any ultrasound contrast agent
  • Evidence right-to-left, bi-directional, or transient cardiac shunt; unexplained pulmonary hypertension (PA systolic pressure \>40 mm Hg) or more than moderate reduction in left ventricular systolic function identified on screening echo.
  • Allergy to eggs
  • Inability to perform modest plantar flexion exercise

Outcomes

Primary Outcomes

Skeletal muscle perfusion during exercise stress

Time Frame: 1 month

Calf skeletal muscle perfusion will be assessed by contrast-enhanced ultrasound during calf raise exercise (every 3 seconds for 30 seconds). This assessment will be performed before and 3-4 weeks after revascularization.

Secondary Outcomes

  • Skeletal muscle perfusion at rest.(1 month)

Study Sites (1)

Loading locations...

Similar Trials